Nduba, Videlis
van’t Hoog, Anna H.
de Bruijn, Annefleur
Mitchell, Ellen M. H.
Laserson, Kayla
Borgdorff, Martien
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (IP_07_32080_003)
Aeras Global Tuberculosis Vaccine Foundation
Article History
Received: 19 April 2019
Accepted: 24 July 2019
First Online: 2 August 2019
Ethics approval and consent to participate
: The protocol and informed consent forms were reviewed and approved by the Kenya Medical Research Institute (KEMRI) local and national scientific steering committees and the KEMRI national ethical review committee (SSC 1295) and the Institutional Review Boards (IRBs) of CDC and the AERAS Global TB Vaccine Foundation. Written informed parental consent was obtained from all parents/guardians at home by study staff prior to inviting adolescents to a mobile field site where minor assent was obtained prior to study participation.
: Not applicable
: KNCV tuberculosis foundation provided some funding for the project and participated in Manuscript preparation. The other funding agencies did not participate in data analysis or the preparation of this manuscript or in the decision to submit the manuscript for publication. The authors have no conflicts of interest relevant to this article to disclose.